BCAT2 and pancreatic neoplasm: Acetylating lysine 44 (K44), an evolutionarily relatively conserved residue located at the N-terminus of BCAT2, of BCAT2 promotes BCAT2 degradation and inhibits BCAA catabolism and pancreatic cancer growth (Lei et al., 2020).